Noncanonical vancomycin resistance cluster from Desulfitobacterium hafniense Y51

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 7, 2009, Pages 2841-2845

  Kalan, Lindsay ^a   Ebert, Sara ^b   Kelly, Tom ^c   Wright, Gerard D ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCOPEPTIDE; LACTIC ACID; LIGASE; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ANIMAL CELL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DESULFITOBACTERIUM; DESULFITOBACTERIUM HAFNIENSE Y51; GENE CLUSTER; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; VANA DH GENE; VANA GENE; VANAWK MURFX GENE CLUSTER; VANH GENE; VANHAX GENE; VANX GENE;

ANTI-BACTERIAL AGENTS; DESULFITOBACTERIUM; DRUG RESISTANCE, BACTERIAL; MULTIGENE FAMILY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VANCOMYCIN RESISTANCE;

EID: 67650000549     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01408-08     Document Type: Article

References (24)

1. Arthur, M., and P. Courvalin. 1993. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563-1571.
2. Arthur, M., C. Molinas, and P. Courvalin. 1992. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 174:2582-2591.
3. Bateman, A., M. T. Holden, and C. Yeats. 2005. The G5 domain: a potential N-acetylglucosamine recognition domain involved in biofilm formation. Bioinformatics 21:1301-1303.
4. Bugg, T. D., G. D. Wright, S. Dutka-Malen, M. Arthur, P. Courvalin, and C. T. Walsh. 1991. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. Biochemistry 30:10408-10415.
5. CLSI. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 7th ed. Approved standard M11-A7, vol. 27. CLSI, Wayne, PA.
6. D'Costa, V. M., K. M. McGrann, D. W. Hughes, and G. D. Wright. 2006. Sampling the antibiotic resistome. Science 311:374-377.
7. El Zoeiby, A., F. Sanschagrin, and R. C. Levesque. 2003. Structure and function of the Mur enzymes: development of novel inhibitors. Mol. Microbiol. 47:1-12.
8. Guardabassi, L., and Y. Agerso. 2006. Genes homologous to glycopeptide resistance vanA are widespread in soil microbial communities. FEMS Microbiol. Lett. 259:221-225.
9. Guardabassi, L., H. Christensen, H. Hasman, and A. Dalsgaard. 2004. Members of the genera Paenibacillus and Rhodococcus harbor genes homologous to enterococcal glycopeptide resistance genes vanA and vanB. Antimicrob. Agents Chemother. 48:4915-4918.
10. Guardabassi, L., B. Perichon, J. van Heijenoort, D. Blanot, and P. Courvalin. 2005. Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil. Antimicrob. Agents Chemother. 49:4227-4233.
11. Hong, H. J., M. I. Hutchings, L. M. Hill, and M. J. Buttner. 2005. The role of the novel Fem protein VanK in vancomycin resistance in Streptomyces coelicolor. J. Biol. Chem. 280:13055-13061.
12. Hong, H. J., M. I. Hutchings, J. M. Neu, G. D. Wright, M. S. Paget, and M. J. Buttner. 2004. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance. Mol. Microbiol. 52:1107-1121.
13. Kahne, D., C. Leimkuhler, W. Lu, and C. Walsh. 2005. Glycopeptide and lipoglycopeptide antibiotics. Chem. Rev. 105:425-448.
14. Leatherbarrow, R. J. 1992. GraFit 4.0.21. Erithacus Software Ltd., Horley, United Kingdom.
15. Levine, D. P. 2006. Vancomycin: a history. Clin. Infect. Dis. 42(Suppl. 1):S5-S12.
16. ΔΔCT method. Methods 25:402-408.
17. Marshall, C. G., I. A. Lessard, I. Park, and G. D. Wright. 1998. Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms. Antimicrob. Agents Chemother. 42:2215-2220.
18. Nonaka, H., G. Keresztes, Y. Shinoda, Y. Ikenaga, M. Abe, K. Naito, K. Inatomi, K. Furukawa, M. Inui, and H. Yukawa. 2006. Complete genome sequence of the dehalorespiring bacterium Desulfitobacterium hafniense Y51 and comparison with Dehalococcoides ethenogenes 195. J. Bacteriol. 188: 2262-2274.
19. Pootoolal, J., M. G. Thomas, C. G. Marshall, J. M. Neu, B. K. Hubbard, C. T. Walsh, and G. D. Wright. 2002. Assembling the glycopeptide antibiotic scaffold: the biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009. Proc. Natl. Acad. Sci. USA 99:8962-8967.
20. Reynolds, P. E., H. A. Snaith, A. J. Maguire, S. Dutka-Malen, and P. Courvalin. 1994. Analysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174. Biochem. J. 301:5-8.
21. Villemur, R., M. Lanthier, R. Beaudet, and F. Lepine. 2006. The Desulfito-bacterium genus. FEMS Microbiol. Rev. 30:706-733.
22. Wampler, D. E., and E. W. Westhead. 1968. Two aspartokinases from Escherichia coli. Nature of the inhibition and molecular changes accompanying reversible inactivation. Biochemistry 7:1661-1671.
23. Wright, G. D. 2007. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 5:175-186.
24. Zawadzke, L. E., T. D. Bugg, and C. T. Walsh. 1991. Existence of two D-alanine:D-alanine ligases in Escherichia coli: cloning and sequencing of the ddlA gene and purification and characterization of the DdlA and DdlB enzymes. Biochemistry 30:1673-1682.